Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
(Stockholm, 14 February 2022) Inhalation Sciences (ISAB) is updating its Quality Management System - strengthening its competitiveness and efficiency in preclinical settings but also preparing for future use in clinical environments. ISAB will implement EN ISO 13485 with full implementation to be completed by June 2022.
ISO 13485 implementation is widely recognized as a prestigious and trusted stamp of quality throughout the MedTech industry. It is associated with improved efficiencies, speed and consistency of service and operations - and higher customer satisfaction.
ISAB is now upgrading its Quality Management System (QMS) and is implementing EN ISO 13485 in the company. The new QMS is expected to deliver benefits in ISAB's current preclinical work, and to lay a robust foundation, together with the recently performed clinical study performed on the flagship system PreciseInhale®.
CEO Manoush Masarrat: "This is a valuable and natural step forward for us and our customers. It will benefit and refine our processes in our current and future settings. ISAB has always been totally committed to delivering a standard of excellence and precision to its customers that enables them to effectively de-risk their research and development work. This upgrade is a natural extension of that."